Biotech Distributor BDI Pharma, Inc. (Formerly known as Blood Diagnostics, Inc.) Introduces Pathway Purchasing Network; New Addition to Executive Team

COLUMBIA, SC--(Marketwire - January 17, 2011) -

BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of biotech therapies, announced that the company has finalized the establishment of Pathway Purchasing Network, a physician/clinic oriented purchasing group, and introduced Cynthia Robbins as Vice President of the new contracting entity.

“Our goal is to be the essential business partner to oncology practices and specialty pharmaceutical manufacturers that have a focus in cancer care,” stated Ms. Robbins. “Pathway Purchasing Network will provide both physician office and clinic based oncology practices with cost effective products and innovative programs. The Network will also offer collaborative opportunities for manufacturers to deliver key clinical messages, patient adherence programs and patient assistance programs through communication channels provided by BDI Pharma and Pathway Purchasing Network that allow manufacturers and healthcare providers to function as partners in improving cancer patients’ lives.”

“We are very pleased to be in a position to continue providing enhanced options, value and service for our customers. These basic needs have been limited for far too long to those physician practices and clinics that provide their patients specialty biopharmaceuticals and chemotherapies throughout the country,” stated Richard J. Gaton, Co-President of BDI Pharma. “In addition to the announcement of Pathway Purchasing Network, it is equally exciting to introduce Cynthia Robbins as a member of the BDI Pharma/Pathway Purchasing Network team. Her experience and expertise in specialty pharmaceutical purchasing and group contracting is a valuable and timely addition to the BDI Pharma family. Our ongoing commitment to find and invest in solutions for our customers demonstrates that BDI Pharma understands the financial pressures under which the health care community is forced to operate, and that we as an organization are working diligently to bring value to them on a daily basis.”

About BDI Pharma, Inc.

Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation’s healthcare community through innovative inventory supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent need delivery. An open-access resource for reference material, educational literature, market data and online ordering, www.bdipharma.com (www.ivig.com) has become an industry-renowned point of reference. Proprietary programs for veterinarians -- www.4legpharma.com; product consignment -- www.consignadvantage.com; flu vaccine pre-booking -- www.securiflu.com; vaccine ordering -- www.securivax.com; and purchasing/reward programs -- www.qoreprogram.com and www.securigam.com round out a family of solutions tailored to the needs of the healthcare community at large.

BDI Pharma’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.